These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22947159)

  • 61. Glomerulopathy in dogs with congenital portosystemic shunts.
    Tisdall PL; Rothwell TL; Hunt GB; Malik R
    Aust Vet J; 1996 Feb; 73(2):52-4. PubMed ID: 8660199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Whole blood manganese concentrations in dogs with primary hepatitis.
    Kilpatrick S; Jacinto A; Foale RD; Tappin SW; Burton C; Frowde PE; Elwood CM; Powell R; Duncan A; Mellanby RJ; Gow AG
    J Small Anim Pract; 2014 May; 55(5):241-6. PubMed ID: 24593275
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts.
    Favier RP; de Graaf E; Corbee RJ; Kummeling A
    Vet Q; 2020 Dec; 40(1):108-114. PubMed ID: 32194008
    [No Abstract]   [Full Text] [Related]  

  • 64. Hepatic organelle pathology in dogs with congenital portosystemic shunts.
    Rutgers HC; Batt RM; Haywood S; Riley JE
    J Vet Intern Med; 1991; 5(6):351-6. PubMed ID: 1685752
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidence and risk factors for neurological signs after attenuation of a single congenital portosystemic shunt in 50 cats.
    Strickland R; Tivers MS; Fowkes RC; Lipscomb VJ
    Vet Surg; 2021 Feb; 50(2):303-311. PubMed ID: 32691934
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival and prognostic indicators for dogs with intrahepatic portosystemic shunts: 32 cases (1990-2000).
    Papazoglou LG; Monnet E; Seim HB
    Vet Surg; 2002; 31(6):561-70. PubMed ID: 12415525
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Untargeted metabolomic profiling of serum from dogs with chronic hepatic disease.
    Lawrence YA; Bishop MA; Honneffer JB; Cook AK; Rodrigues-Hoffmann A; Steiner JM; Suchodolski JS; Lidbury JA
    J Vet Intern Med; 2019 May; 33(3):1344-1352. PubMed ID: 30891842
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Congenital portosystemic shunts in cats: surgical management and prognosis.
    Tivers M; Lipscomb V
    J Feline Med Surg; 2011 Mar; 13(3):185-94. PubMed ID: 21338943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatic hepcidin gene expression in dogs with a congenital portosystemic shunt.
    Frowde PE; Gow AG; Burton CA; Powell R; Lipscomb VJ; House AK; Mellanby RJ; Tivers MS
    J Vet Intern Med; 2014; 28(4):1203-5. PubMed ID: 24962818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical characteristics of, prognostic factors for, and long-term outcome of dogs with multiple acquired portosystemic shunts: 72 cases (2000-2018).
    Anglin EV; Lux CN; Sun X; Folk CA; Fazio C
    J Am Vet Med Assoc; 2021 Dec; 260(S1):S30-S39. PubMed ID: 34914626
    [TBL] [Abstract][Full Text] [Related]  

  • 71. American Cocker Spaniel chronic hepatitis in Japan.
    Kanemoto H; Sakai M; Sakamoto Y; Spee B; van den Ingh TS; Schotanus BA; Ohno K; Rothuizen J
    J Vet Intern Med; 2013; 27(5):1041-8. PubMed ID: 23782303
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Morphometric and cytological disturbances of pancreatic islets evoked by congenital portosystemic shunt in dogs.
    Frymus J; Trębacz P; Sobczak-Filipiak M; Czopowicz M; Galanty M
    Pol J Vet Sci; 2021 Dec; 24(4):465-471. PubMed ID: 35179836
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unusual haemodynamics in two dogs and two cats with portosystemic shunt - implications for distinguishing between congenital and acquired conditions.
    Ricciardi M
    Open Vet J; 2017; 7(2):86-94. PubMed ID: 28616388
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatic organelle pathology in dogs with CPSS.
    Bartsch RC
    J Vet Intern Med; 1992; 6(3):198. PubMed ID: 1619598
    [No Abstract]   [Full Text] [Related]  

  • 75. Spectroscopic and mechanical evaluation of thin film commonly used for banding congenital portosystemic shunts in dogs.
    Smith RR; Hunt GB; Garcia-Nolen TC; Stump S; Stover SM
    Vet Surg; 2013 May; 42(4):478-87. PubMed ID: 23550728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ascites is a negative prognostic indicator in chronic hepatitis in dogs.
    Raffan E; McCallum A; Scase TJ; Watson PJ
    J Vet Intern Med; 2009; 23(1):63-6. PubMed ID: 19175722
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of the Fecal Microbiome in Dogs Receiving Medical Management for Congenital Portosystemic Shunts.
    Squire N; Lux C; Tolbert K; Lidbury J; Sun X; Suchodolski JS
    Front Vet Sci; 2022; 9():897760. PubMed ID: 35968011
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Physical examination, serum biochemical, and coagulation abnormalities, treatments, and outcomes for dogs with toxicosis from α-amanitin-containing mushrooms: 59 cases (2006-2019).
    Kaae JA; Poppenga RH; Hill AE
    J Am Vet Med Assoc; 2021 Mar; 258(5):502-509. PubMed ID: 33620242
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Starvation and the clinicopathologic abnormalities associated with starved dogs: a review of 152 cases.
    Pointer E; Reisman R; Windham R; Murray L
    J Am Anim Hosp Assoc; 2013; 49(2):101-7. PubMed ID: 23325600
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Historical, physical examination, and clinicopathologic features of portosystemic vascular anomalies in the dog and cat.
    Center SA; Magne ML
    Semin Vet Med Surg Small Anim; 1990 May; 5(2):83-93. PubMed ID: 2196649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.